RESUMEN
INTRODUCTION: Electronic health records (EHR) are of great value for clinical research. However, EHR consists primarily of unstructured text which must be analysed by a human and coded into a database before data analysis- a time-consuming and costly process limiting research efficiency. Natural language processing (NLP) can facilitate data retrieval from unstructured text. During AssistMED project, we developed a practical, NLP tool that automatically provides comprehensive clinical characteristics of patients from EHR, that is tailored to clinical researchers needs. MATERIAL AND METHODS: AssistMED retrieves patient characteristics regarding clinical conditions, medications with dosage, and echocardiographic parameters with clinically oriented data structure and provides researcher-friendly database output. We validate the algorithm performance against manual data retrieval and provide critical quantitative and qualitative analysis. RESULTS: AssistMED analysed the presence of 56 clinical conditions, medications from 16 drug groups with dosage and 15 numeric echocardiographic parameters in a sample of 400 patients hospitalized in the cardiology unit. No statistically significant differences between algorithm and human retrieval were noted. Qualitative analysis revealed that disagreements with manual annotation were primarily accounted to random algorithm errors, erroneous human annotation and lack of advanced context awareness of our tool. CONCLUSIONS: Current NLP approaches are feasible to acquire accurate and detailed patient characteristics tailored to clinical researchers' needs from EHR. We present an in-depth description of an algorithm development and validation process, discuss obstacles and pinpoint potential solutions, including opportunities arising with recent advancements in the field of NLP, such as large language models.
Asunto(s)
Cardiología , Procesamiento de Lenguaje Natural , Humanos , Registros Electrónicos de Salud , Algoritmos , Almacenamiento y Recuperación de la InformaciónRESUMEN
INTRODUCTION: Electronic health records (EHRs) contain data valuable for clinical research. However, they are in textual format and require manual encoding to databases, which is a lengthy and costly process. Natural language processing (NLP) is a computational technique that allows for text analysis. OBJECTIVES: Our study aimed to demonstrate a practical use case of NLP for a large retrospective study cohort characterization and comparison with human retrieval. PATIENTS AND METHODS: Anonymized discharge documentation of 10 314 patients from a cardiology tertiary care department was analyzed for inclusion in the CRAFT registry (Multicenter Experience in Atrial Fibrillation Patients Treated with Oral Anticoagulants; NCT02987062). Extensive clinical characteristics regarding concomitant diseases, medications, daily drug dosages, and echocardiography were collected manually and through NLP. RESULTS: There were 3030 and 3029 patients identified by human and NLPbased approaches, respectively, reflecting 99.93% accuracy of NLP in detecting AF. Comprehensive baseline patient characteristics by NLP was faster than human analysis (3 h and 15 min vs 71 h and 12 min). The calculated CHA2DS2VASc and HASBLED scores based on both methods did not differ (human vs NLP; median [interquartile range], 3 [2-5] vs 3 [2-5]; P = 0.74 and 1 [1-2] vs 1 [1-2]; P = 0.63, respectively). For most data, an almost perfect agreement between NLP- and human-retrieved characteristics was found; daily dosage identification was the least accurate NLP feature. Similar conclusions on cohort characteristics would be made; however, daily dosage detection for some drug groups would require additional human validation in the NLPbased cohort. CONCLUSIONS: NLP utilization in EHRs may accelerate data acquisition and provide accurate information for retrospective studies.
Asunto(s)
Fibrilación Atrial , Registros Electrónicos de Salud , Procesamiento de Lenguaje Natural , Humanos , Femenino , Masculino , Anciano , Estudios Retrospectivos , Persona de Mediana Edad , Fibrilación Atrial/tratamiento farmacológico , Almacenamiento y Recuperación de la Información/métodos , Anticoagulantes/uso terapéuticoRESUMEN
INTRODUCTION: Pulmonary vein isolation (PVI) is a recommended strategy for rhythm control in atrial fibrillation (AF), but its success rate remains unsatisfactory. Continuous research is being conducted to explore new technologies and modifications to the existing ablation workflow in order to reduce the arrhythmia recurrence rate. OBJECTIVES: This study aimed to determine the influence of the distance between ablation lines (DBL) on AF recurrence rate in patients undergoing their first PVI; and thus to optimize the procedure outcomes. PATIENTS AND METHODS: This is a retrospective cohort study conducted at a tertiary care center in Poland. A total of 146 patients (median age, 62 years; women, 34.3%) referred for a first PVI for either paroxysmal (n = 103) or persistent (n = 43) AF were evaluated. The procedures were performed with the use of a veryhighpower, shortduration catheter (QDot MicroTM, Biosense Webster, Inc., Irvine, California, United States) or a conventional, ablation index-guided ThermoCool Smarttouch SF catheter (Biosense Webster, Inc.). Freedom from AF recurrence was used as a primary end point. The impact of DBL on the outcome of PVI, accounting for conventional risk factors, was evaluated. RESULTS: Greater distance between opposite circumferential PVI lines and its ratio to the transverse diameter of the left atrium (DLB/TD) were associated with a lower risk of AF recurrence (hazard ratio [HR], 0.966; 95% CI, 0.935-0.998 [per 1 mm]; P = 0.04 and HR, 0.968; 95% CI, 0.944-0.993 [per 1%]; P = 0.01, respectively). There was no correlation between DBL or DBL/TD ratio and the impedance level. CONCLUSIONS: Close distance between PVI lines contributes to AF recurrence; thus, increasing the DBL and ensuring a higher DBL/TD ratio may be an advantageous ablation strategy.